ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...

ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth ...

RMD's stellar second-quarter fiscal 2025 results reflect the ongoing momentum and strong execution across all areas of its ...

ResMed stock tumbled Friday after organic sales growth slowed somewhat in the second fiscal quarter. But one analyst was upbeat.

ResMed’s competitive edge is strong, but its current valuation seems inflated. Read why RMD stock might be ripe for ...

William Blair lowered their Q3 2025 EPS estimates for ResMed in a research report issued on Monday, February 3rd. William Blair analyst M. Andrew now anticipates that the medical equipment provider ...

Chicago Partners Investment Group LLC acquired a new stake in shares of ResMed Inc. (NYSE:RMD – Free Report) during the 4th ...

ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Operational efficiency was highlighted by a 9% increase in selling, general, and administrative expenses that still managed to decrease as a percentage of revenue. The quarter saw ResMed continue ...